Randomized Phase II Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2018
At a glance
- Drugs Axitinib (Primary)
- Indications Adenoid-cystic-carcinoma
- Focus Therapeutic Use
- Acronyms AxitinibACC
- 05 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 10 Sep 2017 Planned primary completion date changed from 1 Sep 2018 to 1 Sep 2017.
- 13 Jan 2017 Status changed from not yet recruiting to recruiting.